CURI

Curis Lifesciences Limited Stock Price

NSEI:CURIS Community·₹1.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CURIS Share Price Performance

₹134.05
-6.95 (-4.93%)
₹134.05
-6.95 (-4.93%)
Price ₹134.05

CURIS Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with slight risk.

4 Risks
2 Rewards

Curis Lifesciences Limited Key Details

₹496.5m

Revenue

₹352.3m

Cost of Revenue

₹144.2m

Gross Profit

₹83.1m

Other Expenses

₹61.1m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
7.55
29.04%
12.30%
96.2%
View Full Analysis

About CURIS

Founded
2010
Employees
93
CEO
Dharmesh Patel
WebsiteView website
curisls.com

Curis Lifesciences Limited operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India. The company's business model operates through loan license manufacturing, through which, the company carry outs manufacturing under Loan License arrangement for domestic suppliers, where all raw materials and excipients are procured and delivered by the client; contract manufacturing, where the company carry outs manufacturing under Contract Manufacturing arrangement for merchant exporters and domestic suppliers, where it would be responsible for procuring and handling all ingredients, raw materials, and packaging materials; and Direct Export/Own Brand Manufacturing, under which the company manufactures products registered by itself in foreign country and sells the said products in foreign country through its distribution. Curis Lifesciences Limited was founded in 2010 and is based in Sanand, India.

Recent CURIS News & Updates

Recent updates

No updates